JUST OUT: Global Pharma Report 2023 I Download now
The results are based on Caliber’s real-time tracking study that measures public perceptions of the CAC40 companies in France on a daily basis.
The 2022 full-year results are based on approx. 16,000 evaluations representing the French population.
How it works
Book a demo
© 2022 Group Caliber | All Rights Reserved | VAT: DK39314320